PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
23542179-2	2014	This study provides important evidence for inhibition of hepatocellular carcinoma (HCC) growth by 15-PGDH through the 15-keto-prostaglandin E2 (15-keto-PGE2)/peroxisome proliferator-activated receptor-gamma (PPARgamma)/p21(WAF1/Cip1) signaling pathway.	keto-prostaglandin e2	121-142	hydroxyprostaglandin dehydrogenase 15 (NAD)	Mus musculus	98-105
23542179-2	2014	This study provides important evidence for inhibition of hepatocellular carcinoma (HCC) growth by 15-PGDH through the 15-keto-prostaglandin E2 (15-keto-PGE2)/peroxisome proliferator-activated receptor-gamma (PPARgamma)/p21(WAF1/Cip1) signaling pathway.	keto-prostaglandin e2	121-142	peroxisome proliferator activated receptor gamma	Mus musculus	208-217
23542179-2	2014	This study provides important evidence for inhibition of hepatocellular carcinoma (HCC) growth by 15-PGDH through the 15-keto-prostaglandin E2 (15-keto-PGE2)/peroxisome proliferator-activated receptor-gamma (PPARgamma)/p21(WAF1/Cip1) signaling pathway.	keto-prostaglandin e2	121-142	cyclin-dependent kinase inhibitor 1A (P21)	Mus musculus	219-222
23542179-2	2014	This study provides important evidence for inhibition of hepatocellular carcinoma (HCC) growth by 15-PGDH through the 15-keto-prostaglandin E2 (15-keto-PGE2)/peroxisome proliferator-activated receptor-gamma (PPARgamma)/p21(WAF1/Cip1) signaling pathway.	keto-prostaglandin e2	121-142	cyclin-dependent kinase inhibitor 1A (P21)	Mus musculus	223-227
23542179-2	2014	This study provides important evidence for inhibition of hepatocellular carcinoma (HCC) growth by 15-PGDH through the 15-keto-prostaglandin E2 (15-keto-PGE2)/peroxisome proliferator-activated receptor-gamma (PPARgamma)/p21(WAF1/Cip1) signaling pathway.	keto-prostaglandin e2	121-142	cyclin-dependent kinase inhibitor 1A (P21)	Mus musculus	228-232